Characterization of Sox9-overexpressing human umbilical cord blood-derived mesenchymal stem cells-based engineered cartilage both in vitro and in vivo.

about

Characterization of Sox9-overexpressing human umbilical cord blood-derived mesenchymal stem cells-based engineered cartilage both in vitro and in vivo.

Item

http://www.wikidata.org/entity/Q50190841

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Characterization of Sox9-overe ...... age both in vitro and in vivo.

@en

Characterization of Sox9-overe ...... age both in vitro and in vivo.

@nl

type

Item

label

Characterization of Sox9-overe ...... age both in vitro and in vivo.

@en

Characterization of Sox9-overe ...... age both in vitro and in vivo.

@nl

prefLabel

Characterization of Sox9-overe ...... age both in vitro and in vivo.

@en

Characterization of Sox9-overe ...... age both in vitro and in vivo.

@nl

P1476

Characterization of Sox9-overe ...... age both in vitro and in vivo.

@en

P2093

A-Ling Zhang

http://www.w3.org/2001/XMLSchema#string

Hua-Nan Luo

http://www.w3.org/2001/XMLSchema#string

Jun Zhang

http://www.w3.org/2001/XMLSchema#string

Xiao-Li Li

http://www.w3.org/2001/XMLSchema#string

Xiao-Yan Zhao

http://www.w3.org/2001/XMLSchema#string

Zheng-Hui Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Should we use cells, biomaterials, or tissue engineering for cartilage regeneration?

In vitro cartilage tissue engineering using cancellous bone matrix gelatin as a biodegradable scaffold.

Umbilical cord mesenchymal stem cells suppress host rejection: the role of the glycocalyx.

The TLR7 agonist Imiquimod promote the immunogenicity of mesenchymal stem cells.

Chm-1 gene-modified bone marrow mesenchymal stem cells maintain the chondrogenic phenotype of tissue-engineered cartilage.

Transplantation of umbilical cord-derived mesenchymal stem cells as a novel strategy to protect the central nervous system: technical aspects, preclinical studies, and clinical perspectives.

Isolation, expansion and characterisation of mesenchymal stem cells from human bone marrow, adipose tissue, umbilical cord blood and matrix: a comparative study.

Comparison of proliferative and multilineage differentiation potentials of cord matrix, cord blood, and bone marrow mesenchymal stem cells.

Delivery of the Sox9 gene promotes chondrogenic differentiation of human umbilical cord blood-derived mesenchymal stem cells in an in vitro model

SOX9 gene transfer via safe, stable, replication-defective recombinant adeno-associated virus vectors as a novel, powerful tool to enhance the chondrogenic potential of human mesenchymal stem cells.

P304

1150-1155

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JBM.A.35989

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28028895

http://www.w3.org/2001/XMLSchema#string

P921

overexpression